Maze Therapeutics receives positive ratings following recent IPO
Go back to Maze Therapeutics receives positive ratings following recent IPO| (NASDAQ: MAZE) | Delayed: 24.48 -0.34 (1.37%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $24.82 | 52 Week High | $ | |||
| Open | $25.14 | 52 Week Low | $ | |||
| Day High | $25.99 | P/E | N/A | |||
| Day Low | $24.46 | EPS | $ | |||
| Volume | 689,850 | |||||
| Vertex Pharmaceuticals Inc (NASDAQ: VRTX) | Delayed: 514.11 -0.45 (0.09%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $514.56 | 52 Week High | $134.71 | |||
| Open | $522.10 | 52 Week Low | $73.31 | |||
| Day High | $522.10 | P/E | N/A | |||
| Day Low | $511.81 | EPS | $-1.98 | |||
| Volume | 198,333 | |||||
